Gerald E Quirk insider trades

Open-market stock purchases and sales by Gerald E Quirk, Chief Legal & Compliance Offic at Syros Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 5, 2010.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • SYRS Syros Pharmaceuticals, Inc: 1 sale, last Nov 19, 2024
  • TKAI Tokai Pharmaceuticals Inc: other filings, last Dec 15, 2015
  • INFI Infinity Pharmaceuticals, Inc: other filings, last Jan 6, 2012

Get free alerts when Gerald E Quirk files a new trade →